Amylyx Pharmaceuticals: Citigroup raises target price to $39 from $32
AMLX•Citigroup raised its target price for Amylyx Pharmaceuticals to $39 from $32.
Related News
Granite Construction publishes update to financial calendar
GVA•
US Foods to host third-quarter results conference call and webcast
USFD•
Rocket Pharmaceuticals participates in Chardan’s 10th annual healthcare conference
RCKT•
Stifel cuts Vital Farms target price to $9 from $11
VITL•
British GDP growth not pressuring the BoE, say Berenberg
TLT•